On 9 September 2021, the Commission released the updated Delirium Clinical Care Standard (2021).

Update 23 provides data submitted to CARAlert for the reporting period 1 May 2021 to 30 June 2021to support prevention and containment of antimicrobial resistance.

This issue includes items on COVID-19, the draft Opioid Analgesic Stewardship Clinical Care Standard, Clostridioides difficile infection, medical imaging, diagnosis, safety culture and more.

Also covered is the latest issue of the Journal for Healthcare Quality along with the latest online papers from BMJ Quality & Safety and International Journal for Quality in Health Care and the latest from the UK’s NICE and NIHR and the USA’s AHRQ.

There are a number of reasons why your learner profile may have been suspended. This document will provide you with information regarding what you need to do to take action regarding your learner profile in the National Hand Hygiene Initiative LMS.

The Diagnostic Imaging Accreditation Scheme Standards provide a consistent statement on the level of care consumers can expect from diagnostic imaging practices. The standards aim to protect the public from harm and improve the quality of imaging delivered.

The consultation has now closed. 

This issue includes items on COVID-19, the AURA 2021 report on antimicrobial use and resistance, blood culture practice, learning from patient safety incidents, medication safety interventions and more.

Also covered is the latest issue of the Journal of Patient Safety along with the latest online papers from BMJ Quality & Safety and International Journal for Quality in Health Care and the latest from the UK’s NICE and the USA’s AHRQ.

On 27 August 2021, the Commission released the Fourth Australian report on antimicrobial use and resistance in human health (AURA 2021).

This document provides guidance to support temporary collection facilities during the evolving coronavirus disease 2019 (COVID-19) outbreak.

This document provides guidance from the National Pathology Accreditation Advisory Council (NPAAC) on the use of point of care testing to support increased testing demand for SARS-CoV-2 during the coronavirus disease 2019 (COVID-19) outbreak.